Bone Biologics (BBLGW) Enterprise Value (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Enterprise Value for 2 consecutive years, with -$1.6 million as the latest value for Q3 2017.
- Quarterly Enterprise Value fell 135.67% to -$1.6 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Sep 2017, down 135.67% year-over-year, with the annual reading at -$620375.0 for FY2016, N/A changed from the prior year.
- Enterprise Value for Q3 2017 was -$1.6 million at Bone Biologics, down from -$783014.0 in the prior quarter.
- The five-year high for Enterprise Value was -$620375.0 in Q4 2016, with the low at -$4.2 million in Q1 2016.